Press release
Inotropic Agents Global Market Report 2024: Key Players, Demand Patterns And Forecasts 2033
Inotropic Agents Market
The Business Research Company offers in-depth market insights through Inotropic Agents Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The inotropic agents market size has grown rapidly in recent years. It will grow from $2.32 billion in 2023 to $2.59 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to education and awareness initiatives, expansion of cardiac treatment options, development of safer agents, improved patient outcomes, regulatory approvals.
The inotropic agents market size is expected to see rapid growth in the next few years. It will grow to $4.01 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to growing cardiovascular disease burden, advancements in drug delivery systems, personalized medicine approach, increasing research funding, demand for combination therapies. Major trends in the forecast period include patient education and awareness, targeting cardiomyopathies, focus on heart failure management, combination therapies, improved safety profiles.
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=10711&type=smp
Market Segmentation:
The inotropic agents market covered in this report is segmented -
1) By Type: Positive Inotropic Drugs, Negative Inotropic Drugs, Other Types
2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
3) By Indication: Heart Attack, Heart Failure, Angina, Arrhythmia, Other Indications
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
5) By End User: Hospital, Homecare, Specialty Centers, Other End Users
Major Driver - Surging Cardiovascular Diseases Propel Growth In The Inotropic Agent Market
The surge in the prevalence of cardiovascular diseases is driving the inotropic agent market. Cardiovascular diseases (CVDs) refer to diseases of the vascular system and heart functioning. Inotropic agents are used in the treatment of cardiovascular diseases to improve the contractility and function of the heart, tackle cardiac shock, and slow the heart rate as they help the heart contract more powerfully, thereby increasing blood flow. So this helps boost the inotropic agent market. For instance, in October 2022, according to the reports shared by the Centers for Disease Control and Prevention, a US-based government agency, heart diseases were the leading cause of death in the US. About 697,000 people died from heart disease in 2020, which was roughly 1 in every 5 deaths. About 20.1 million adults were suffering from coronary artery disease. Each year, about 805,000 people in the US suffer from a heart attack. Furthermore, in August 2022, according to the American College of Cardiology, a US-based nonprofit medical association, the risk of stroke was expected to increase by 33.8 percent to 15 million from 2025 to 2060. Therefore, the surge in the prevalence of cardiovascular diseases is propelling the inotropic agent market forward.
Competitive Landscape:
Major companies operating in the inotropic agents market report are Pfizer Inc., GSK plc, Novartis AG, Mylan N.V., Boehringer Ingelheim International GmbH, AstraZeneca plc, Johnson & Johnson, Bayer AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Cipla Ltd., Eli Lilly And Company, Sanofi S.A., Baxter International Inc., Hikma Pharmaceuticals plc, Sun Pharmaceuticals Industries Ltd., Cadila Pharmaceuticals Ltd., AbbVie Inc., Allergan plc, Amgen Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Fresenius Kabi AG, Genentech Inc., GlaxoSmithKline plc, Intas Pharmaceuticals Ltd., Lupin Limited, Regeneron Pharmaceuticals Inc., Roche Holding AG, BioNTech SE
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/inotropic-agents-global-market-report
Top Trend - Bristol-Myers Squibb's Mavacamten Receives Fda Approval, Setting A Trend In The Inotropic Agents Market
Drug approval is a key trend gaining popularity in the inotropic agents market. Major companies in the market are developing innovative new products and drugs to sustain their position in the market. For instance, in April 2022, Bristol-Myers Squibb., a US-based pharmaceutical developer and manufacturer, received regulatory approval for Camzyos™ (mavacamten) from the U.S. Food and Drug Administration (FDA), a US-based national public health agency and regulator. It is used in the treatment of class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms. This medication works by inhibiting the excessive contraction of the heart muscle. It is a selective inhibitor of cardiac myosin, a protein involved in muscle contraction. It is typically prescribed to individuals who have symptomatic obstructive HCM and have not adequately responded to other treatment options, such as beta-blockers or calcium channel blockers.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Inotropic Agents Market Characteristics
3. Inotropic Agents Market Trends And Strategies
4. Inotropic Agents Market - Macro Economic Scenario
5. Inotropic Agents Market Size And Growth
…..
27. Inotropic Agents Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Inotropic Agents Global Market Report 2024: Key Players, Demand Patterns And Forecasts 2033 here
News-ID: 3431819 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Inotropic
Surging Cardiovascular Diseases Propel Growth In The Inotropic Agent Market: Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Inotropic Agents Market Through 2025?
The market size for inotropic agents has expanded significantly in the previous years. The market is expected to increase from $2.56 billion in 2024 to $2.84 billion in 2025, indicating a compound annual growth rate (CAGR) of…
Inotropic Agent Market Key Players, Share and Forecast Outlook
On May 13 , 2025, Exactitude Consultancy., Ltd. released a research report titled "Inotropic Agent Market". This report covers the global Inotropic Agent market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034 and future market trends. Along…
Inotropic Agent Market Key Players, Share and Forecast Outlook
On May 12 , 2025, Exactitude Consultancy., Ltd. released a research report titled "Inotropic Agent Market". This report covers the global Inotropic Agent market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034 and future market trends. Along…
Surging Cardiovascular Diseases Propel Growth In The Inotropic Agent Market Driv …
What market dynamics are playing a key role in accelerating the growth of the inotropic agents market?
The increase in occurrences of cardiovascular diseases is fueling the growth of the inotropic agent market. Cardiovascular diseases, which pertain to disorders of the heart and vascular system, are often treated with inotropic agents. These substances enhance the heart's contractility, help manage cardiac shock, and slow down the heart rate by assisting the heart…
Inotropic Agents Market: Exploring Size, Growth Rate, Drivers, and Trends
Expanding Scope and Implications of Inotropic Agents in Cardiac Health
What Is The Projected Market Size Of The Global Inotropic Agents Market And Its Growth Rate?
The inotropic agents market has seen a significant growth, driven by the medical advancements and the rising awareness of cardiac health.
• Market size in 2024: $2.56 billion
• Market size in 2025: $2.84 billion (11.1% CAGR)
• Expected Market size in 2029: $4.52 billion (12.3% CAGR)
The key factors…
Insights into Inotropic Agents Market: Global Trends and Analysis
The inotropic agents market size has grown rapidly in recent years. It will grow from $2.32 billion in 2023 to $2.59 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to education and awareness initiatives, expansion of cardiac treatment options, development of safer agents, improved patient outcomes, regulatory approvals.
The inotropic agents market size is expected to…
